{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:03:14Z","timestamp":1793473394477,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008613","name":"Wesley Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008613","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GA89314"],"award-info":[{"award-number":["GA89314"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1067807"],"award-info":[{"award-number":["1067807"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ebiom.2025.105840","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:34:42Z","timestamp":1751589282000},"page":"105840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Phase 2a\/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis"],"prefix":"10.1016","volume":"118","author":[{"given":"Matthew","family":"Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Manoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Sly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Wainwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Wolvetang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Feenstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maharshi S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Hermith-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahn","family":"Preece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Zappala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Webber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrey","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutham","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy S.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magtouf","family":"Gatei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Sandona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lewindon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine G.","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Nayler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F.","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Coman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2025.105840_bib1","first-page":"255","article-title":"Ataxia-telangiectasia: some historic, clinical and pathological observations","volume":"11","author":"Boder","year":"1975","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105840_bib2","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/mds.25126","article-title":"A randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia","volume":"27","author":"Zannolli","year":"2012","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105840_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105840_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12311-021-01257-4","article-title":"Neurofilament light chain is a biomarker of neurodegeneration in ataxia telangiectasia","volume":"21","author":"Donath","year":"2022","journal-title":"Cerebellum"},{"key":"10.1016\/j.ebiom.2025.105840_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejpn.2021.04.002","article-title":"Neurofilament light chain: a novel blood biomarker in patients with ataxia telangiectasia","volume":"32","author":"Veenhuis","year":"2021","journal-title":"Eur J Paediatr Neurol"},{"issue":"138","key":"10.1016\/j.ebiom.2025.105840_bib6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1183\/16000617.0066-2015","article-title":"ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia","volume":"24","author":"Bhatt","year":"2015","journal-title":"Eur Respir Rev"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105840_bib7","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/dmcn.13424","article-title":"Ataxia-telangiectasia: recomendations for multidisciplinary treatment","volume":"59","author":"van Os","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ebiom.2025.105840_bib8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fimmu.2016.00210","article-title":"Chronic inflammation and \u03b3\u03b4 T cells","volume":"7","author":"Fay","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2025.105840_bib9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fped.2019.00458","article-title":"Porgressive Liver disease in patients with ataia telangiectasia","volume":"7","author":"Donath","year":"2019","journal-title":"Front Pediatr"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105840_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ana.25394","article-title":"Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasia","volume":"85","author":"Schon","year":"2019","journal-title":"Ann Neurol"},{"issue":"5218","key":"10.1016\/j.ebiom.2025.105840_bib11","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A single ataxia telangiectasia gene with a product similar to PI-3 kinase","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"issue":"6922","key":"10.1016\/j.ebiom.2025.105840_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature01368","article-title":"DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation","volume":"421","author":"Bakkenist","year":"2003","journal-title":"Nature"},{"issue":"6003","key":"10.1016\/j.ebiom.2025.105840_bib13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1126\/science.1192912","article-title":"ATM activation by oxidative stress","volume":"330","author":"Guo","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105840_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/gcc.20267","article-title":"Regulation of the Atm promoter in vivo","volume":"45","author":"Gueven","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105840_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM Protein Kinase: regulating the cellular response to genotoxic stress, and more","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105840_bib16","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2011-08-373639","article-title":"Mitochondrial dysfunction in ataxia-telangiectasia","volume":"119","author":"Valentin-Vega","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105840_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1164\/rccm.201611-2210LE","article-title":"Loss of ATM in airway epithelial cells is associated with susceptibility to oxidative stress","volume":"196","author":"Yeo","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105840_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190821","article-title":"A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant","volume":"13","author":"Rimkus","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105840_bib19","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cmet.2016.09.004","article-title":"NAD+ replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair","volume":"24","author":"Fang","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2025.105840_bib20","article-title":"ATM mediates spermidine-induced mitophagy via PINK1 and Parkin regulation in human fibroblasts","volume":"6","author":"Qi","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105840_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101972","article-title":"Impaired endoplasmic reticulum-mitochondrial signaling in ataxia-telangiectasia","volume":"24","author":"Yeo","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.ebiom.2025.105840_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101354","article-title":"An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)","volume":"54","author":"Yeo","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.ebiom.2025.105840_bib23","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10545-017-0085-8","article-title":"Triheptanoin vs trictanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial","volume":"40","author":"Gillingham","year":"2017","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105840_bib24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10545-010-9090-x","article-title":"Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening","volume":"33","author":"Spiekerkoetter","year":"2010","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105840_bib25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/jimd.12640","article-title":"Triheptanoin for the treatment of long-chain fatty acid oxidation disorders: final results of an open-label, long-term extension study","volume":"46","author":"Vockley","year":"2023","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ebiom.2025.105840_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ymgme.2015.06.006","article-title":"Long-term clinical outcomes in patients with long chain fatty acid oxidation disorders before and after triheptanoin treatment-a retrospective chart review","volume":"116","author":"Vockley","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"2\u20133","key":"10.1016\/j.ebiom.2025.105840_bib27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s10545-006-0290-3","article-title":"Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential","volume":"29","author":"Roe","year":"2006","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105840_bib28","doi-asserted-by":"crossref","first-page":"E860","DOI":"10.1152\/ajpendo.00366.2005","article-title":"Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats","volume":"291","author":"Kinman","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"41","key":"10.1016\/j.ebiom.2025.105840_bib29","doi-asserted-by":"crossref","first-page":"27799","DOI":"10.1074\/jbc.M109.048744","article-title":"Interrelations between C4 ketogenesis, C5 ketogenesis, and anaplerosis in the perfused rat liver","volume":"284","author":"Deng","year":"2009","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105840_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/jcbfm.2012.151","article-title":"Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain","volume":"33","author":"Marin-Valencia","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105840_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/jnc.12610","article-title":"Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy","volume":"129","author":"Hadera","year":"2014","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105840_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jimd.12313","article-title":"Effects of triheptanoin (UX007) in patients with long-chain fatty acid oxidation disorders: results from an open-label, long-term extension study","volume":"44","author":"Vockley","year":"2021","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105840_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jimd.12199","article-title":"Therapeutic potential of triheptanoin in metabolic and neurodegenerative diseases","volume":"43","author":"Wehbe","year":"2020","journal-title":"J Inherit Metab Dis"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105840_bib34","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/jnr.24111","article-title":"Triheptanoin for the treatment of brain energy deficit: a 14-year experience","volume":"95","author":"Mochel","year":"2017","journal-title":"J Neurosci Res"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105840_bib35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ymgme.2019.01.008","article-title":"Ketogenic and anaplerotic dietary modifications ameliorate seizure activity in Drosophila models of mitochondrial encephalomyopathy and glycolytic enzymopathy","volume":"126","author":"Fogle","year":"2019","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105840_bib36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.nbd.2010.07.017","article-title":"Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models","volume":"40","author":"Willis","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105840_bib37","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/mds.29822","article-title":"Triheptanoin did not show benefit versus placebo for the treatment of paroxysmal movement disorders in Glut1 deficiency syndrome: results of a randomized phase 3 study","volume":"39","author":"Giorgis","year":"2024","journal-title":"Mov Disord"},{"issue":"2\u20133","key":"10.1016\/j.ebiom.2025.105840_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/08977194.2017.1367681","article-title":"Growth hormone treatment in patients with ataxia telangiectasia","volume":"35","author":"Woelke","year":"2017","journal-title":"Growth Factors"},{"key":"10.1016\/j.ebiom.2025.105840_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-9-5","article-title":"Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trial","volume":"9","author":"Chessa","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"36","key":"10.1016\/j.ebiom.2025.105840_bib40","doi-asserted-by":"crossref","first-page":"11453","DOI":"10.1523\/JNEUROSCI.23-36-11453.2003","article-title":"Oxidative stress is responsible for deficient survival and dendritogenesis in purkinje neurons from ataxia-telangiectasia mutated mutant mice","volume":"23","author":"Chen","year":"2003","journal-title":"J Neurosci"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105840_bib41","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/mds.28788","article-title":"Nicotinamide riboside improves ataxia scores and immunoglobulin levels in ataxia telangiectasia","volume":"36","author":"Veenhuis","year":"2021","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105840_bib42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/mds.29645","article-title":"Long-term nicotinamide riboside use improves coordination and eye movements in ataxia telangiectasia","volume":"39","author":"Presterud","year":"2024","journal-title":"Mov Disord"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105840_bib43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S1474-4422(24)00220-5","article-title":"Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial","volume":"23","author":"Zielen","year":"2024","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105840_bib44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/mdc3.12315","article-title":"Standardized assessment of hereditary ataxia patients in clinical studies","volume":"3","author":"Paap","year":"2016","journal-title":"Mov Disord Clin Pract"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105840_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejpn.2015.09.002","article-title":"Development of global rating instruments for pediatric patients with ataxia telangiectasia","volume":"20","author":"Nissenkorn","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105840_bib46","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00415-017-8499-7","article-title":"Clinical assessment of dysphagia in neurodegeneration (CADN): development, validity and reliability of a bedside tool for dysphagia assessment","volume":"264","author":"Vogel","year":"2017","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105840_bib47","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s12311-023-01623-4","article-title":"Quantitative speech assessment in ataxia-consensus recommendations by the ataxia global initiative working group on digital-motor markers","volume":"23","author":"Vogel","year":"2024","journal-title":"Cerebellum"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105840_bib48","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/acn3.51613","article-title":"Home-based biofeedback speech treatment improves dysarthria in repeat-expansion SCAs","volume":"9","author":"Vogel","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105840_bib49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/brainsci12020197","article-title":"Feasibility of a telerehabilitation adaptation of the Be clear speech treatment program for non-progressive dysarthria","volume":"12","author":"Whelan","year":"2022","journal-title":"Brain Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105840_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/ene.14523","article-title":"Speech metrics, general disability, brain imaging and quality of life in multiple sclerosis","volume":"28","author":"Noffs","year":"2021","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105840_bib51","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.rdc.2023.06.004","article-title":"Deficiency of adenosine Deaminase 2: clinical manifestations, diagnosis, and treatment","volume":"49","author":"Grim","year":"2023","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105840_bib52","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/mrm.26893","article-title":"Feasibility of quantitative regional ventilation and perfusion mapping with phase-resolved functional lung (PREFUL) MRI in healthy volunteers and COPD, CTEPH, and CF patients","volume":"79","author":"Voskrebenzev","year":"2018","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.ebiom.2025.105840_bib53","series-title":"3rd int conf learn represent ICLR 2015 \u2013 cong track proc","first-page":"1","article-title":"Very deep convolutional networks for large-scale image recognition","author":"Simonyan","year":"2015"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105840_bib54","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/jmri.26799","article-title":"MRI-derived regional flow-volume loop parameters detect early-stage chronic lung allograft dysfunction","volume":"50","author":"Alsady","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ebiom.2025.105840_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103269","article-title":"Oxidative stress and the multifaceted roles of ATM in maintaining cellular redox homeostasis","volume":"75","author":"Lee","year":"2024","journal-title":"Redox Biol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105840_bib56","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105840_bib57","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2249.2006.03221.x","article-title":"Impaired interferon-gamma production in response to live bacteria and Toll-like receptor agonists in patients with ataxia telangiectasia","volume":"146","author":"Reichenbach","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ebiom.2025.105840_bib58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.iy.13.040195.001343","article-title":"Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity","volume":"13","author":"Trinchieri","year":"1995","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105840_bib59","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ebiom.2025.105840_bib60","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fimmu.2018.00719","article-title":"TCR signaling abnormalities in human Th2-associated atopic disease","volume":"9","author":"Milner","year":"2018","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105840_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13468","article-title":"Inhibition of the cGAS-STING pathway ameliorates the premature senescence hallmarks of Ataxia-Telangiectasia brain organoids","volume":"20","author":"Aguado","year":"2021","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105840_bib62","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaci.2017.10.030","article-title":"Type I IFN-related NETosis in ataxia telangiectasia and artemis deficiency","volume":"142","author":"Gul","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ebiom.2025.105840_bib63","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41419-024-06911-3","article-title":"ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC class I","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ebiom.2025.105840_bib64","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/ana.27081","article-title":"Interferon stimulated gene expression is a biomarker for primary mitochondrial disease","volume":"96","author":"Keshavan","year":"2024","journal-title":"Ann Neurol"},{"issue":"7971","key":"10.1016\/j.ebiom.2025.105840_bib65","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41586-023-06277-0","article-title":"A framework for individualized splice-switching oligonucleotide therapy","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425002841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425002841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:38:46Z","timestamp":1778873926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425002841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":65,"alternative-id":["S2352396425002841"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105840","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 2a\/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105882","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105840"}}